Deferasirox Dispersible Tablets 250mg

Deferasirox Dispersible Tablets 250mg Technical Specification:

GENERIC NAME OF THE MEDICINAL PRODUCT:

• Deferasirox Dispersible Tablets USP100mg
• Deferasirox Dispersible Tablets USP125mg
• Deferasirox Dispersible Tablets USP 250mg
• Deferasirox Dispersible Tablets USP 400mg
• Deferasirox Dispersible Tablets USP 500mg

QUALITATIVE AND QUANTITATIVE COMPOSITION:

• a) Deferasirox Dispersible Tablets 100mg
  Each uncoated dispersible tablet contains:
  Deferasirox……………………….100mg
  Exipients……………………………q.s.
• b) Deferasirox Dispersible Tablets 125mg
  Each uncoated dispersible tablet contains:
  Deferasirox……………………….125mg
  Exipients……………………………q.s.
• c) Deferasirox Dispersible Tablets 250mg
  Each uncoated dispersible tablet contains:
  Deferasirox……………………….250mg
  Exipients……………………………q.s.
• d) Deferasirox Dispersible Tablets 400mg
  Each uncoated dispersible tablet contains:
  Deferasirox……………………….400mg
  Exipients……………………………q.s.
• e) Deferasirox Dispersible Tablets 500mg
  Each uncoated dispersible tablet contains:
  Deferasirox……………………….500mg
  Exipients……………………………q.s.

THERAPEUTIC INDICATIONS:

• Deferasirox is used to remove excess iron from the body in patients who have had too many blood transfusions and in patients with non-transfusion dependent thalassemia syndromes. Deferasirox is an iron chelator (binder). it combines with iron in the blood.

CAUTION & WARNING:

• CAUTION:
  Read enclosed leaflet before use.
  Keep medicine out of reach of children.
  DO NOT CHEW OR SWALLOW WHOLE.
  Take this medicine on an empty stomach.
  Dispense tablet in water before consuming.
  Take Defrataj once daily on an empty stomach at least 30 minutes before food, preferably at the same time each day. Completely disperse tablet by stirring in water until a finesuspension obtained.
• Warning: To be sold by retail on the prescription of a Registered Medical Practitioner only.

STORAGE & DOSAGE:

• Storage:  Store Deferasirox tablets at 25°C (77°F); excursions are permitted to 15°C-30°C (59°F-86°F) [see USP Controlled Room Temperature]. Protect from moisture.
• Dosage:  As directed by the Physician.

Introduction to Deferasirox Dispersible Tablets 250mg

Deferasirox Dispersible Tablets 250mg are an advanced oral iron chelator medication widely prescribed for the treatment of chronic iron overload in patients receiving frequent blood transfusions. This condition is commonly associated with inherited blood disorders such as beta-thalassemia, sickle cell disease, and myelodysplastic syndromes. Excess iron accumulation in the body can lead to severe organ damage if left untreated, making iron chelation therapy a critical component of long-term patient care.

As a potent chelating agent, Deferasirox binds excess iron in the bloodstream and facilitates its elimination primarily through the stools, thereby reducing iron levels to safer ranges. Due to its oral dispersible formulation, Deferasirox offers greater patient compliance compared to injectable chelators, especially for pediatric and long-term therapy patients.

Globally, the demand for Deferasirox Dispersible Tablets 250mg is rising steadily due to increased awareness of iron overload complications, improved diagnosis rates, and expanding access to transfusion therapy. Developing regions across Asia, Africa, the Middle East, Latin America, and CIS countries are witnessing particularly strong growth in demand.

Taj Pharma, a well-known Deferasirox Dispersible Tablets 250mg manufacturer in India, assures high-quality, high-purity, and globally compliant formulations. Manufactured at its state-of-the-art facilities in Vapi, Gujarat, Taj Pharma supplies this critical medicine to domestic and international markets with complete regulatory and quality assurance.

Therapeutic Uses & Clinical Benefits

Taj Pharma’s Deferasirox Dispersible Tablets 250mg are used in:

• Treatment of chronic iron overload caused by frequent blood transfusions

• Long-term iron chelation therapy in patients with thalassemia major

• Prevention of iron-induced organ damage involving the liver, heart, and endocrine organs

Excess iron in the body (iron overload) can lead to serious complications such as:

• Liver cirrhosis

• Irregular heartbeat

• Diabetes

• Joint disorders (arthritis)

• Increased cancer risk

By removing excess iron from the body, Deferasirox Dispersible Tablets 250mg help reduce these risks and improve patient outcomes.

Dosage & Administration Guidance

• Tablet should be taken on an empty stomach

• Disperse the tablet completely in water or juice before consumption

• Take at the same time every day for maximum benefit

• Follow the exact dose and duration prescribed by the physician

Common Side Effects

Some patients may experience:

• Nausea

• Headache

• Constipation

• Diarrhea

If side effects persist or worsen, medical advice should be sought. Patients should inform their doctor if they have kidney or liver disease or are taking other medications to ensure safe use.

In-Depth Details for Importers, Exporters & Global Buyers

As a trusted Deferasirox Dispersible Tablets 250mg supplier from India, Taj Pharma offers comprehensive support tailored to international pharmaceutical markets.

Regulatory Documentation Provided

Taj Pharma facilitates smooth and fast product registration by providing:

• Certificate of Pharmaceutical Product (COPP)

• WHO-GMP Manufacturing Certificate

• EU-GMP support (country-specific)

• Certificate of Analysis (CoA)

• Stability Data & Reports

• Batch Manufacturing Records

• Material Safety Data Sheets (MSDS)

• CTD / ACTD Dossiers for regulated and semi-regulated markets

Custom Packaging & Labeling

To meet diverse global requirements, Taj Pharma offers:

• Customized blister and bottle packaging

• Private labeling and contract manufacturing

• Multilingual labeling as per importing country norms

• Hospital packs, retail packs, and tender-based packaging

Shelf-Life, Storage & Dosage Form

• Dosage Form: Dispersible Tablet

• Strength: 250mg

• Shelf Life: 36 months

• Storage Conditions: Store below 25°C, protect from moisture and light

Export Certifications

• WHO-GMP Certified Manufacturing Facility

• ISO-Certified Quality Management Systems

• GDP-compliant logistics and warehousing

• Pharmacovigilance and post-marketing support

Target Countries & Export Markets

Taj Pharma exports Deferasirox Dispersible Tablets 250mg to:

• Africa

• Southeast Asia

• Middle East

• CIS Countries

• Latin America

• Select regulated markets

Why Taj Pharma Is the Most Trusted Manufacturer, Supplier & Exporter

State-of-the-Art Manufacturing Facilities

Taj Pharma’s manufacturing units in Vapi, Gujarat, are equipped with:

• Modern, automated tablet compression and coating lines

• Dedicated quality control and stability laboratories

• Stringent adherence to WHO-GMP guidelines

• Comprehensive validation and documentation systems

This ensures batch-to-batch consistency, safety, and efficacy for global buyers.

Affordable Pricing with Uncompromised Quality

As a PAN India manufacturer and exporter, Taj Pharma leverages India’s cost-efficient pharmaceutical ecosystem to provide competitive and sustainable pricing. Each batch undergoes:

• Raw material qualification

• In-process quality control

• Final product testing

Global Presence & Supply Chain Support

Taj Pharma supports international partners with:

• Reliable and timely shipments

• Flexible order quantities

• Regulatory assistance during product registration

• Long-term distributor and franchise partnerships

Top 20 Countries Where Taj Pharma Exports

India , Bangladesh, Nepal, Sri Lanka, Vietnam, Philippines, Cambodia, Nigeria, Kenya, Ghana, Egypt, Ethiopia, Morocco, Peru, Colombia, Ecuador, Bolivia , Ukraine, Uzbekistan, Kazakhstan

Technical Product Specification 

PAN India Presence & PCD Pharma Franchise Opportunity

Taj Pharma is a PAN India manufacturer with strong operations in Vapi, Gujarat, Mumbai, Maharashtra, and other major pharmaceutical hubs. The company offers Deferasirox Dispersible Tablets 250mg PCD Pharma Franchise, providing:

• Monopoly marketing rights

• Promotional and branding support

• Assured product availability

• Attractive margins for franchise partners

Call to Action 

If you are searching for a Leading 1 Deferasirox Dispersible Tablets 250mg Manufacturer & Supplier in India, Taj Pharma is your trusted global partner. We serve pharmaceutical importers, distributors, hospitals, NGOs, and government procurement agencies with quality, compliance, and reliability.

👉 Contact Taj Pharma today for export inquiries, bulk orders, private labeling, or PCD franchise opportunities.

Top 20 FAQs

1. What is Deferasirox Dispersible Tablets 250mg used for?
   It is used to treat chronic iron overload due to frequent blood transfusions.

2. Is Taj Pharma a WHO-GMP manufacturer?
   Yes, Taj Pharma is WHO-GMP certified.

3. Where is Taj Pharma located?
   Vapi, Gujarat, India.

4. How should the tablet be taken?
   On an empty stomach after dispersing in liquid.

5. What are the common side effects?
   Nausea, headache, constipation, and diarrhea.

6. Is kidney function monitoring required?
   Yes, kidney and liver function should be monitored.

7. Does Taj Pharma export globally?
   Yes, to over 20 countries worldwide.

8. Is private labeling available?
   Yes.

9. What is the shelf life?
   36 months.

10. Do you provide COPP?
    Yes.

11. Is CTD dossier support available?
    Yes.

12. Can it be used in pediatric patients?
    As prescribed by a doctor.

13. Is this product suitable for tenders?
    Yes.

14. Is Taj Pharma a PAN India supplier?
    Yes.

15. Do you offer PCD Pharma Franchise?
    Yes.

16. Is export packaging customizable?
    Yes.

17. Which markets are targeted?
    Africa, Asia, CIS, Middle East, and Latin America.

18. Is batch-wise quality testing done?
    Yes.

19. Does it reduce organ damage risk?
    Yes, by lowering excess iron levels.

20. Why choose Taj Pharma?
    Trusted quality, regulatory expertise, and global reach.